Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Renovaro Biosciences (DE:2Q5)
FRANKFURT:2Q5
Holding DE:2Q5?
Track your performance easily
Renovaro Biosciences (2Q5) Ownership Overview
73.73% Insiders
4.64% Mutual Funds
4.94% Other Institutional Investors
16.68% Public Companies and
Individual Investors
The ownership structure of Renovaro Biosciences (DE:2Q5) stock is a mix of institutional, retail and individual investors. Approximately 9.59% of the company’s stock is owned by Institutional Investors, 73.73% is owned by Insiders and 16.68% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 19, 2024 | William Anderson Wittekind >10% Owner | xxxxxxxxxxxxx | $23889 |
| Jul 17, 2024 | William Anderson Wittekind >10% Owner | xxxxxxxxxxxxx | $30955 |
| Jul 15, 2024 | William Anderson Wittekind >10% Owner | xxxxxxxxxxxxx | $142827 |
| Jul 08, 2024 | William Anderson Wittekind >10% Owner | xxxxxxxxxxxxx | $168500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,455,560 | Institution | 3.70% | 2,362,257 | |
| 5,211,725 | Institution | 3.53% | 2,256,677 | |
| 1,727,327 | Institution | 1.17% | 747,933 | |
| 523,617 | Institution | 0.35% | 226,726 | |
| 396,648 | Institution | 0.27% | 171,749 | |
| 198,966 | Institution | 0.13% | 86,152 | |
| 184,328 | Institution | 0.12% | 79,814 | |
| 70,239 | Institution | 0.05% | 30,413 | |
| 68,157 | Institution | 0.05% | 29,512 | |
| 64,442 | Institution | 0.04% | 27,903 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,211,725 | Institution | 3.53% | 2,256,677 | |
| 523,617 | Institution | 0.35% | 226,726 | |
| 396,648 | Institution | 0.27% | 171,749 | |
| 198,966 | Institution | 0.13% | 86,152 | |
| 184,328 | Institution | 0.12% | 79,814 | |
| 70,239 | Institution | 0.05% | 30,413 | |
| 68,157 | Institution | 0.05% | 29,512 | |
| 64,442 | Institution | 0.04% | 27,903 | |
| 35,933 | Institution | 0.02% | 15,559 | |
| 25,852 | Institution | 0.02% | 11,194 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Renovaro Biosciences (DE:2Q5)?
According to the latest TipRanks data, approximately 4.94% of the company's stock is held by institutional investors, 73.73% is held by insiders, and 16.68% is held by retail investors.
What percentage of Renovaro Biosciences (DE:2Q5) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.94% of Renovaro Biosciences (DE:2Q5) stock is held by institutional investors.
What percentage of Renovaro Biosciences (DE:2Q5) stock is held by retail investors?
According to the latest TipRanks data, approximately 16.68% of Renovaro Biosciences (DE:2Q5) stock is held by retail investors.
Who owns the most shares of Renovaro Biosciences (DE:2Q5)?
Vanguard owns the most shares of Renovaro Biosciences (DE:2Q5).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.